What is the regulatory review period in patent term extension?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30
This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice.
The regulatory review period is a crucial component in calculating patent term extension. According to 35 U.S.C. 156(g), the regulatory review period has specific meanings for different types of products. MPEP 2758 states:
“The Office will rely on the Secretary’s determination of the length of the regulatory review period when calculating the length of the extension period under 37 CFR 1.775 – 1.779.”
Key points about the regulatory review period:
- It’s determined by the relevant regulatory agency (e.g., FDA)
- Only the portion occurring after the patent was granted is considered for extension
- Periods of lack of due diligence by the applicant are subtracted
- Half days are ignored in the calculation
Topics:
Adjustments
And Extensions
MPEP 2700 - Patent Terms
MPEP 2758 - Notice Of Final Determination - Calculation Of Patent Term Extension
Patent Law
Patent Procedure